MEGAN PHILLIPS: Open Payments
NPI 1093350928 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,759 in 116 payments from 13 companies in 2025. Trend: 2023 $1,814 · 2024 $1,546 · 2025 $1,759
Food & beverage: $1,759
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 23 | $348 |
| Braeburn Inc. | 11 | $191 |
| Alkermes, Inc. | 12 | $189 |
| ABBVIE INC. | 15 | $179 |
| Otsuka America Pharmaceutical, Inc. | 16 | $175 |
| Vanda Pharmaceuticals Inc. | 9 | $154 |
| Janssen Pharmaceuticals, Inc | 10 | $153 |
| Axsome Therapeutics, Inc. | 7 | $130 |
| Teva Pharmaceuticals USA, Inc. | 6 | $112 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
Products named: COBENFY, BRIXADI, VRAYLAR, ARISTADA, INVEGA SUSTENNA, Auvelity, FANAPT, ABILIFY ASIMTUFII.
Industry payments across KY — which companies pay providers there.
